BeOne Medicines Ltd
196 hedge funds and large institutions have $6.12B invested in BeOne Medicines Ltd in 2019 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 82 increasing their positions, 50 reducing their positions, and 29 closing their positions.
64% more repeat investments, than reductions
Existing positions increased: 82 | Existing positions reduced: 50
1% more capital invested
Capital invested by funds: $6.09B → $6.12B (+$32.5M)
0.05% more ownership
Funds ownership: 6.35% → 6.4% (+0.05%)
0% more funds holding in top 10
Funds holding in top 10: 10 → 10 (0)
3% less funds holding
Funds holding: 203 → 196 (-7)
15% less call options, than puts
Call options by funds: $30.1M | Put options by funds: $35.2M
17% less first-time investments, than exits
New positions opened: 24 | Existing positions closed: 29
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital International Investors
Los Angeles,
California
|
+$144M |
| 2 |
HA
HHLR Advisors
Grand Cayman,
Cayman Islands
|
+$137M |
| 3 |
CII
Capital International Inc
Los Angeles,
California
|
+$82.6M |
| 4 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
+$51.9M |
| 5 |
ICP
Indus Capital Partners
New York
|
+$35.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
-$42.7M |
| 2 |
Rockefeller Capital Management
New York
|
-$31.2M |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$29.5M |
| 4 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
-$15.8M |
| 5 |
MICM
Matthews International Capital Management
San Francisco,
California
|
-$14.9M |
ONC Hedge Fund Activity: Q3 2019 in Review
196 of the 4,574 institutional investors tracked by Wall St. Rank reported a position in BeOne Medicines Ltd (ONC) for Q3 2019, worth a combined $6.12B — up 0.53% from $6.09B a quarter earlier.
Sellers outnumbered buyers: 29 funds closed out of ONC and 24 opened new positions — a net loss of 5 holders — while 50 trimmed existing stakes and 82 added.
The largest buyer was Capital International Investors, adding an estimated $144M. The largest seller was Invesco, cutting an estimated $42.7M.
- 196 institutional investors held BeOne Medicines Ltd (ONC) as of Q3 2019, down from 203 in Q2 2019.
- Funds reported $6.12B of BeOne Medicines Ltd stock for Q3 2019, up 0.53% quarter-over-quarter.
- 24 funds opened new BeOne Medicines Ltd positions in Q3 2019 and 29 closed out, a net change of -5 holders.
- The largest BeOne Medicines Ltd buyer in Q3 2019 was Capital International Investors, an estimated $144M added.
- The largest BeOne Medicines Ltd seller in Q3 2019 was Invesco, an estimated $42.7M sold.
Based on aggregated 13F filings for Q3 2019.